Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Return on Equity (2018 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Return on Equity for 8 consecutive years, with 0.46% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 31.0% year-over-year to 0.46%, compared with a TTM value of 0.46% through Oct 2025, up 31.0%, and an annual FY2025 reading of 0.57%, up 29.0% over the prior year.
  • Return on Equity was 0.46% for Q4 2025 at VitaNova Life Sciences, up from 0.46% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.1% in Q1 2023 and bottomed at 11.15% in Q1 2022.
  • Average Return on Equity over 5 years is 0.9%, with a median of 0.19% recorded in 2021.
  • The sharpest move saw Return on Equity plummeted -1133bps in 2022, then skyrocketed 1225bps in 2023.
  • Year by year, Return on Equity stood at 5.25% in 2021, then skyrocketed by 108bps to 0.42% in 2022, then soared by 69bps to 0.71% in 2023, then tumbled by -79bps to 0.15% in 2024, then surged by 209bps to 0.46% in 2025.
  • Business Quant data shows Return on Equity for YJGJ at 0.46% in Q4 2025, 0.46% in Q3 2025, and 0.56% in Q2 2025.